Cardiorenal syndrome at different stages of chronic kidney disease

G Tsagalis1, S Zerefos, N Zerefos

  • 1Renal Unit, Ygia Hospital, Athens, Greece. tsagalis@otenet.gr

Insights

Cardiorenal syndrome (CRS) involves complex heart-kidney interactions affecting blood pressure and fluid balance. Understanding these connections is key to developing effective treatments for this common condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Pathophysiology

Background:

  • Cardiorenal syndrome (CRS) highlights the intricate relationship between cardiac and renal function.
  • The heart and kidneys act as interconnected organs, influencing each other through various physiological parameters.
  • Complex interactions involve cardiac output, extracellular volume, blood pressure, and renal sodium handling.

Purpose of the Study:

  • To dissect the multifactorial components of cardiorenal syndrome (CRS).
  • To elucidate the crosstalk between the heart and kidneys.
  • To facilitate the development of targeted therapeutic strategies for CRS.

Main Methods:

  • Review of existing literature on cardiorenal syndrome.
  • Analysis of mediators and antagonists involved in heart-kidney crosstalk.
  • Examination of factors like nitric oxide/reactive oxygen species balance, sympathetic nervous system activation, and inflammation.

Main Results:

  • Identified key parameters governing heart-kidney interactions: cardiac output, volume regulation, blood pressure, and sodium handling.
  • Highlighted the roles of the renin-angiotensin system, endothelin, and natriuretic peptides.
  • Emphasized how imbalances in nitric oxide/reactive oxygen species, sympathetic activation, and inflammation exacerbate CRS.

Conclusions:

  • A holistic understanding of CRS pathogenesis is crucial for effective management.
  • Targeting multiple factors involved in CRS may improve patient prognosis.
  • Further research and clinical trials are needed to address CRS comprehensively.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...